These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 31690612

  • 1. Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study.
    Xiao W, Du LY, Mao B, Miao TW, Fu JJ.
    BMJ Open; 2019 Nov 04; 9(11):e034592. PubMed ID: 31690612
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
    Wang Z, Locantore N, Haldar K, Ramsheh MY, Beech AS, Ma W, Brown JR, Tal-Singer R, Barer MR, Bafadhel M, Donaldson GC, Wedzicha JA, Singh D, Wilkinson TMA, Miller BE, Brightling CE.
    Am J Respir Crit Care Med; 2021 Jun 15; 203(12):1488-1502. PubMed ID: 33332995
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D, Devos N, Lambert C, Brown JR, Clarke SC, Kim VL, Magid-Slav M, Miller BE, Ostridge KK, Patel R, Sathe G, Simola DF, Staples KJ, Sung R, Tal-Singer R, Tuck AC, Van Horn S, Weynants V, Williams NP, Devaster JM, Wilkinson TMA, AERIS Study Group.
    Thorax; 2018 May 15; 73(5):422-430. PubMed ID: 29386298
    [Abstract] [Full Text] [Related]

  • 4. Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease.
    Su L, Qiao Y, Luo J, Huang R, Xiao Y.
    Biomolecules; 2022 Oct 14; 12(10):. PubMed ID: 36291689
    [Abstract] [Full Text] [Related]

  • 5. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
    Huang YJ, Boushey HA.
    Ann Am Thorac Soc; 2015 Nov 14; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK, Quibrera PM, Carretta EE, Barr RG, Bleecker ER, Bowler RP, Cooper CB, Comellas A, Couper DJ, Curtis JL, Criner G, Dransfield MT, Hansel NN, Hoffman EA, Kanner RE, Krishnan JA, Martinez CH, Pirozzi CB, O'Neal WK, Rennard S, Tashkin DP, Wedzicha JA, Woodruff P, Paine R, Martinez FJ, SPIROMICS investigators.
    Lancet Respir Med; 2017 Aug 14; 5(8):619-626. PubMed ID: 28668356
    [Abstract] [Full Text] [Related]

  • 9. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
    Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV.
    J Clin Microbiol; 2014 Aug 14; 52(8):2813-23. PubMed ID: 24850358
    [Abstract] [Full Text] [Related]

  • 10. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
    Tufvesson E, Bjermer L, Ekberg M.
    Int J Chron Obstruct Pulmon Dis; 2015 Aug 14; 10():881-9. PubMed ID: 26005341
    [Abstract] [Full Text] [Related]

  • 11. Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD.
    Dicker AJ, Crichton ML, Cassidy AJ, Brady G, Hapca A, Tavendale R, Einarsson GG, Furrie E, Elborn JS, Schembri S, Marshall SE, Palmer CNA, Chalmers JD.
    Thorax; 2018 Jun 14; 73(6):510-518. PubMed ID: 29101284
    [Abstract] [Full Text] [Related]

  • 12. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
    Baines KJ, Fu JJ, McDonald VM, Gibson PG.
    Int J Chron Obstruct Pulmon Dis; 2017 Jun 14; 12():541-550. PubMed ID: 28223794
    [Abstract] [Full Text] [Related]

  • 13. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY, Li SW, Chin CY, Hsu CW, Lee CC, Yeh YM, Wu KA.
    J Transl Med; 2021 Mar 23; 19(1):121. PubMed ID: 33757530
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
    Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, Haldar K, Kebadze T, Duvoix A, Lindblad K, Patel H, Rugman P, Dodson P, Jenkins M, Saunders M, Newbold P, Green RH, Venge P, Lomas DA, Barer MR, Johnston SL, Pavord ID, Brightling CE.
    Am J Respir Crit Care Med; 2011 Sep 15; 184(6):662-71. PubMed ID: 21680942
    [Abstract] [Full Text] [Related]

  • 17. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
    Wang Z, Singh R, Miller BE, Tal-Singer R, Van Horn S, Tomsho L, Mackay A, Allinson JP, Webb AJ, Brookes AJ, George LM, Barker B, Kolsum U, Donnelly LE, Belchamber K, Barnes PJ, Singh D, Brightling CE, Donaldson GC, Wedzicha JA, Brown JR, COPDMAP.
    Thorax; 2018 Apr 15; 73(4):331-338. PubMed ID: 29269441
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.